Transcatheter Patent Ductus Arteriosus Closure

Also known as: PDA closure, closure of ductus arteriosus by cardiac catheterization.

What is transcatheter patent ductus arteriosus closure?

Patent ductus arteriosus (PDA) is a congenital heart defect that causes the ductus arteriosus, a blood vessel that connects the aorta with the arteries going to the lungs, to remain open. This vessel should normally close in the first several hours after birth. Transcatheter patent ductus arteriosus closure is a method of correcting this defect without the need for a surgical procedure and avoiding a scar on the chest/back.

What happens during the procedure?

A catheter (a long, thin flexible tube) is inserted into a blood vessel in the groin area, and advanced to the PDA.  A device that acts like a plug is inserted into the catheter and placed within the PDA, blocking the abnormal blood flow.

Is any special preparation needed?

You/your child will need to stop taking liquids and food, as well as certain medications, the night before the procedure. If you/your child are taking blood-thinners you may be asked to stop taking them a few days before the procedure.

What are the risks?

Transcatheter PDA closure is a very safe procedure and complications are rare. Potential complications include impingement on surrounding structures, dislodgment of the device, and soreness/bruising at the groin site where the vessels were entered in order to do the procedure.

Transcatheter closure of a patent ductus arteriosus device at Nicklaus Children’s Hospital: Transcatheter closure of a patent ductus arteriosus is performed by Nicklaus Children’s Hospital’s team of top-notch medical professionals using the most cutting edge techniques.


Reviewed by: Lourdes Rosa Prieto, MD

This page was last updated on: 6/18/2018 10:55:12 AM

From the Newsdesk

New anesthesia offering helps cardiac patients recover faster and with less pain
07/05/2018 — In this news story Dr. Kristine Guleserian, renowned heart surgeon, talk about Exparel. Exparel is a new anesthesia offering that helps cardiac patients recover faster and with less pain after heart surgery. 13 year-old Jessica Garcia, born with a congenital heart defect (VSD) was the first pediatric patient to use this treatment.
New anesthesia offering helps cardiac patients recover faster and with less pain
07/05/2018 — In this news story Dr. Kristine Guleserian, renowned heart surgeon, talk about Exparel. Exparel is a new anesthesia offering that helps cardiac patients recover faster and with less pain after heart surgery. 13 year-old Jessica Garcia, born with a congenital heart defect (VSD) was the first pediatric patient to use this treatment.

Video

video
Anthony Rossi, MD of Nicklaus Children's Hospital is the Director of Cardiac Critical Care with The Heart Program.